Article Information
History
- May 29, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Elemuwa Uchenna Geraldine1,*,
- Enato Ehijie2,
- Elemuwa Christopher Ononiwu3,
- Elemuwa Tochukwu Daniel4 and
- Morufu Olalekan Raimi5
- 1National Agency for Food and Drug Administration and Control, NAFDAC, Nigeria
- 2Department of Clinical Pharmacy and Pharmacy Practice, University of Benin, Nigeria
- 3Department of Medical Microbiology, Parasitology and Immunology, Faculty of Medical Laboratory Sciences, Federal University Otuoke, Bayelsa State, Nigeria
- 4Alliance for Sustainable Development Initiative (ASID), Nigeria
- 5Department of Environmental Management and Toxicology, Faculty of Sciences, Federal University Otuoke, Bayelsa State, Nigeria
- ↵*Corresponding Author:
Elemuwa, Uchenna Geraldine, National Agency for Food and Drug Administration and Control, NAFDAC, Plot 2032 Olusegun Obasanjo Way, Wuse Zone 7, Abuja, Nigeria, Tel: + (234) 8034099032. E-mail:
uchenna.elemuwa{at}nafdac.gov.ng; uche2nice2000{at}yahoo.co.uk; enatoefo{at}uniben.edu.ng; elemuwachris{at}yahoo.com; uche2nice2000{at}yahoo.co.uk; elemuwatochukwu2001{at}gmail.com; raimimo{at}fuotuoke.edu.ng.
Posted May 29, 2024.
Pentavalent Vaccine: How Safe Is It Among Infants Accessing Immunization In Nigerian Health Facilities
